638 related articles for article (PubMed ID: 10860729)
21. Individual genetic variations directly effect polarization of cytokine responses to superantigens associated with streptococcal sepsis: implications for customized patient care.
Nooh MM; Nookala S; Kansal R; Kotb M
J Immunol; 2011 Mar; 186(5):3156-63. PubMed ID: 21282506
[TBL] [Abstract][Full Text] [Related]
22. The crystal structure of staphylococcal superantigen-like protein 11 in complex with sialyl Lewis X reveals the mechanism for cell binding and immune inhibition.
Chung MC; Wines BD; Baker H; Langley RJ; Baker EN; Fraser JD
Mol Microbiol; 2007 Dec; 66(6):1342-55. PubMed ID: 18045383
[TBL] [Abstract][Full Text] [Related]
23. Carboxy-terminal residues of major histocompatibility complex class II-associated peptides control the presentation of the bacterial superantigen toxic shock syndrome toxin-1 to T cells.
Wen R; Broussard DR; Surman S; Hogg TL; Blackman MA; Woodland DL
Eur J Immunol; 1997 Mar; 27(3):772-81. PubMed ID: 9079821
[TBL] [Abstract][Full Text] [Related]
24. Three-dimensional structure of a human class II histocompatibility molecule complexed with superantigen.
Jardetzky TS; Brown JH; Gorga JC; Stern LJ; Urban RG; Chi YI; Stauffacher C; Strominger JL; Wiley DC
Nature; 1994 Apr; 368(6473):711-8. PubMed ID: 8152483
[TBL] [Abstract][Full Text] [Related]
25. The crystal structure of exfoliative toxin B: a superantigen with enzymatic activity.
Vath GM; Earhart CA; Monie DD; Iandolo JJ; Schlievert PM; Ohlendorf DH
Biochemistry; 1999 Aug; 38(32):10239-46. PubMed ID: 10441117
[TBL] [Abstract][Full Text] [Related]
26. The bacterial superantigen and superantigen-like proteins.
Fraser JD; Proft T
Immunol Rev; 2008 Oct; 225():226-43. PubMed ID: 18837785
[TBL] [Abstract][Full Text] [Related]
27. Structural basis for the recognition of superantigen streptococcal pyrogenic exotoxin A (SpeA1) by MHC class II molecules and T-cell receptors.
Papageorgiou AC; Collins CM; Gutman DM; Kline JB; O'Brien SM; Tranter HS; Acharya KR
EMBO J; 1999 Jan; 18(1):9-21. PubMed ID: 9878045
[TBL] [Abstract][Full Text] [Related]
28. The structural basis of T cell activation by superantigens.
Li H; Llera A; Malchiodi EL; Mariuzza RA
Annu Rev Immunol; 1999; 17():435-66. PubMed ID: 10358765
[TBL] [Abstract][Full Text] [Related]
29. Bacterial superantigens promote acute nasopharyngeal infection by Streptococcus pyogenes in a human MHC Class II-dependent manner.
Kasper KJ; Zeppa JJ; Wakabayashi AT; Xu SX; Mazzuca DM; Welch I; Baroja ML; Kotb M; Cairns E; Cleary PP; Haeryfar SM; McCormick JK
PLoS Pathog; 2014 May; 10(5):e1004155. PubMed ID: 24875883
[TBL] [Abstract][Full Text] [Related]
30. Topology of T cell receptor-peptide/class I MHC interaction defined by charge reversal complementation and functional analysis.
Chang HC; Smolyar A; Spoerl R; Witte T; Yao Y; Goyarts EC; Nathenson SG; Reinherz EL
J Mol Biol; 1997 Aug; 271(2):278-93. PubMed ID: 9268659
[TBL] [Abstract][Full Text] [Related]
31. Streptococcus pyogenes: Insight into the function of the streptococcal superantigens.
Sriskandan S; Faulkner L; Hopkins P
Int J Biochem Cell Biol; 2007; 39(1):12-9. PubMed ID: 17029999
[TBL] [Abstract][Full Text] [Related]
32. Structural basis of the gp120 superantigen-binding site on human immunoglobulins.
Karray S; Juompan L; Maroun RC; Isenberg D; Silverman GJ; Zouali M
J Immunol; 1998 Dec; 161(12):6681-8. PubMed ID: 9862697
[TBL] [Abstract][Full Text] [Related]
33. Superantigen antagonist blocks Th1 cytokine gene induction and lethal shock.
Arad G; Hillman D; Levy R; Kaempfer R
J Leukoc Biol; 2001 Jun; 69(6):921-7. PubMed ID: 11404377
[TBL] [Abstract][Full Text] [Related]
34. Identification of binding domains on the superantigen, toxic shock syndrome-1, for class II MHC molecules.
Soos JM; Russell JK; Jarpe MA; Pontzer CH; Johnson HM
Biochem Biophys Res Commun; 1993 Mar; 191(3):1211-7. PubMed ID: 8466498
[TBL] [Abstract][Full Text] [Related]
35. The streptococcal superantigen SMEZ exhibits wide allelic variation, mosaic structure, and significant antigenic variation.
Proft T; Moffatt SL; Weller KD; Paterson A; Martin D; Fraser JD
J Exp Med; 2000 May; 191(10):1765-76. PubMed ID: 10811869
[TBL] [Abstract][Full Text] [Related]
36. Identification from a phage display library of peptides that bind to toxic shock syndrome toxin-1 and that inhibit its binding to major histocompatibility complex (MHC) class II molecules.
Sato A; Ida N; Fukuyama M; Miwa K; Kazami J; Nakamura H
Biochemistry; 1996 Aug; 35(32):10441-7. PubMed ID: 8756700
[TBL] [Abstract][Full Text] [Related]
37. A new closed-tube multiplex real-time PCR to detect eleven superantigens of Streptococcus pyogenes identifies a strain without superantigen activity.
Lintges M; Arlt S; Uciechowski P; Plümäkers B; Reinert RR; Al-Lahham A; Lütticken R; Rink L
Int J Med Microbiol; 2007 Oct; 297(6):471-8. PubMed ID: 17481952
[TBL] [Abstract][Full Text] [Related]
38. Residues of the variable region of the T-cell-receptor beta-chain that interact with S. aureus toxin superantigens.
Choi YW; Herman A; DiGiusto D; Wade T; Marrack P; Kappler J
Nature; 1990 Aug; 346(6283):471-3. PubMed ID: 2377208
[TBL] [Abstract][Full Text] [Related]
39. Staphylococcal enterotoxin H displays unique MHC class II-binding properties.
Nilsson H; Björk P; Dohlsten M; Antonsson P
J Immunol; 1999 Dec; 163(12):6686-93. PubMed ID: 10586065
[TBL] [Abstract][Full Text] [Related]
40. Defining a novel domain of staphylococcal toxic shock syndrome toxin-1 critical for major histocompatibility complex class II binding, superantigenic activity, and lethality.
Kum WW; Laupland KB; Chow AW
Can J Microbiol; 2000 Feb; 46(2):171-9. PubMed ID: 10721486
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
